Vertex Pharmaceuticals Stock Shares Outstanding

VRTX Stock  USD 418.01  0.69  0.17%   
Vertex Pharmaceuticals fundamentals help investors to digest information that contributes to Vertex Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Vertex Stock. The fundamental analysis module provides a way to measure Vertex Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vertex Pharmaceuticals stock.
Common Stock Shares Outstanding is likely to drop to about 153.1 M in 2024.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Vertex Shares Outstanding Analysis

Vertex Pharmaceuticals' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
 2021 2022 2023 2024 (projected)
Short and Long Term Debt Total556.7M561M808.4M848.8M
Total Assets13.4B18.2B22.7B23.9B

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Vertex Pharmaceuticals Shares Outstanding

    
  258.31 M  
Most of Vertex Pharmaceuticals' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vertex Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Vertex Shares Outstanding Driver Correlations

Understanding the fundamental principles of building solid financial models for Vertex Pharmaceuticals is extremely important. It helps to project a fair market value of Vertex Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Vertex Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Vertex Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Vertex Pharmaceuticals' interrelated accounts and indicators.
0.961.0-0.980.940.450.590.991.0-0.060.980.990.370.860.040.230.930.870.20.830.440.990.080.66-0.550.780.790.930.920.78
0.960.96-0.920.940.540.480.940.95-0.160.950.940.290.770.040.30.870.810.050.810.490.940.110.55-0.460.670.840.880.870.82
1.00.96-0.980.950.440.570.981.0-0.080.970.990.350.870.010.220.920.870.210.840.441.00.060.66-0.560.790.790.940.920.78
-0.98-0.92-0.98-0.94-0.38-0.54-0.96-0.990.06-0.95-0.99-0.34-0.840.0-0.13-0.89-0.89-0.24-0.84-0.45-0.990.02-0.660.55-0.79-0.68-0.96-0.97-0.69
0.940.940.95-0.940.470.290.890.94-0.120.930.930.070.79-0.140.120.790.810.10.760.580.94-0.070.44-0.350.630.810.90.890.79
0.450.540.44-0.380.470.130.460.430.270.470.430.10.33-0.20.210.230.390.120.350.530.4-0.170.050.110.220.570.370.330.54
0.590.480.57-0.540.290.130.660.580.070.550.590.880.590.410.370.750.540.380.57-0.170.580.360.88-0.80.760.30.510.480.32
0.990.940.98-0.960.890.460.660.990.010.980.980.470.830.120.270.940.870.190.810.430.970.170.68-0.550.780.780.910.90.76
1.00.951.0-0.990.940.430.580.99-0.060.980.990.370.850.030.210.930.890.210.830.441.00.070.65-0.560.780.760.940.940.75
-0.06-0.16-0.080.06-0.120.270.070.01-0.06-0.02-0.040.18-0.18-0.15-0.34-0.060.02-0.11-0.130.19-0.1-0.18-0.040.21-0.1-0.02-0.06-0.040.0
0.980.950.97-0.950.930.470.550.980.98-0.020.960.380.810.10.230.920.810.180.720.470.960.180.57-0.460.690.820.90.890.8
0.990.940.99-0.990.930.430.590.980.99-0.040.960.370.860.020.180.910.90.220.860.450.990.030.67-0.550.80.720.940.940.71
0.370.290.35-0.340.070.10.880.470.370.180.380.370.350.60.510.560.350.280.34-0.10.360.420.72-0.610.480.130.40.380.23
0.860.770.87-0.840.790.330.590.830.85-0.180.810.860.350.010.180.80.660.50.740.280.880.010.7-0.580.820.620.820.770.62
0.040.040.010.0-0.14-0.20.410.120.03-0.150.10.020.60.010.410.210.02-0.050.02-0.10.010.870.31-0.230.0-0.040.110.090.06
0.230.30.22-0.130.120.210.370.270.21-0.340.230.180.510.180.410.280.22-0.060.290.020.210.340.21-0.250.090.250.220.170.27
0.930.870.92-0.890.790.230.750.940.93-0.060.920.910.560.80.210.280.770.20.730.160.930.290.77-0.750.790.730.840.830.72
0.870.810.87-0.890.810.390.540.870.890.020.810.90.350.660.020.220.770.140.890.430.87-0.030.61-0.490.720.550.850.870.53
0.20.050.21-0.240.10.120.380.190.21-0.110.180.220.280.5-0.05-0.060.20.140.06-0.20.25-0.140.43-0.340.550.030.210.180.04
0.830.810.84-0.840.760.350.570.810.83-0.130.720.860.340.740.020.290.730.890.060.40.83-0.070.68-0.550.760.490.830.810.5
0.440.490.44-0.450.580.53-0.170.430.440.190.470.45-0.10.28-0.10.020.160.43-0.20.40.4-0.23-0.060.410.070.410.540.540.5
0.990.941.0-0.990.940.40.580.971.0-0.10.960.990.360.880.010.210.930.870.250.830.40.050.68-0.590.80.760.940.930.75
0.080.110.060.02-0.07-0.170.360.170.07-0.180.180.030.420.010.870.340.29-0.03-0.14-0.07-0.230.050.18-0.22-0.050.19-0.01-0.020.16
0.660.550.66-0.660.440.050.880.680.65-0.040.570.670.720.70.310.210.770.610.430.68-0.060.680.18-0.860.880.370.680.640.47
-0.55-0.46-0.560.55-0.350.11-0.8-0.55-0.560.21-0.46-0.55-0.61-0.58-0.23-0.25-0.75-0.49-0.34-0.550.41-0.59-0.22-0.86-0.73-0.28-0.52-0.5-0.3
0.780.670.79-0.790.630.220.760.780.78-0.10.690.80.480.820.00.090.790.720.550.760.070.8-0.050.88-0.730.480.730.70.49
0.790.840.79-0.680.810.570.30.780.76-0.020.820.720.130.62-0.040.250.730.550.030.490.410.760.190.37-0.280.480.650.590.95
0.930.880.94-0.960.90.370.510.910.94-0.060.90.940.40.820.110.220.840.850.210.830.540.94-0.010.68-0.520.730.650.990.73
0.920.870.92-0.970.890.330.480.90.94-0.040.890.940.380.770.090.170.830.870.180.810.540.93-0.020.64-0.50.70.590.990.66
0.780.820.78-0.690.790.540.320.760.750.00.80.710.230.620.060.270.720.530.040.50.50.750.160.47-0.30.490.950.730.66
Click cells to compare fundamentals
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Vertex Common Stock Shares Outstanding

Common Stock Shares Outstanding

153.1 Million

At this time, Vertex Pharmaceuticals' Common Stock Shares Outstanding is fairly stable compared to the past year.
Based on the latest financial disclosure, Vertex Pharmaceuticals has 258.31 M of shares currently outstending. This is 43.08% higher than that of the Biotechnology sector and 141.74% higher than that of the Health Care industry. The shares outstanding for all United States stocks is 54.83% higher than that of the company.

Vertex Shares Outstanding Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vertex Pharmaceuticals' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vertex Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Vertex Pharmaceuticals by comparing valuation metrics of similar companies.
Vertex Pharmaceuticals is currently under evaluation in shares outstanding category among related companies.

Vertex Pharmaceuticals ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Vertex Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Vertex Pharmaceuticals' managers, analysts, and investors.
Environment Score
Governance Score
Social Score

Vertex Fundamentals

About Vertex Pharmaceuticals Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Vertex Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vertex Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vertex Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
Common Stock Shares Outstanding260.5 M153.1 M

Vertex Pharmaceuticals Investors Sentiment

The influence of Vertex Pharmaceuticals' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Vertex. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Vertex Pharmaceuticals' public news can be used to forecast risks associated with an investment in Vertex. The trend in average sentiment can be used to explain how an investor holding Vertex can time the market purely based on public headlines and social activities around Vertex Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Vertex Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Vertex Pharmaceuticals' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Vertex Pharmaceuticals' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Vertex Pharmaceuticals.

Vertex Pharmaceuticals Implied Volatility

    
  23.01  
Vertex Pharmaceuticals' implied volatility exposes the market's sentiment of Vertex Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Vertex Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Vertex Pharmaceuticals stock will not fluctuate a lot when Vertex Pharmaceuticals' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vertex Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vertex Pharmaceuticals' short interest history, or implied volatility extrapolated from Vertex Pharmaceuticals options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Vertex Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vertex Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vertex Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vertex Pharmaceuticals Stock:
Check out Vertex Pharmaceuticals Piotroski F Score and Vertex Pharmaceuticals Altman Z Score analysis.
For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Complementary Tools for Vertex Stock analysis

When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Bonds Directory
Find actively traded corporate debentures issued by US companies
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Is Vertex Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vertex Pharmaceuticals. If investors know Vertex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vertex Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.181
Earnings Share
13.9
Revenue Per Share
38.297
Quarterly Revenue Growth
0.093
Return On Assets
0.1317
The market value of Vertex Pharmaceuticals is measured differently than its book value, which is the value of Vertex that is recorded on the company's balance sheet. Investors also form their own opinion of Vertex Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Vertex Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vertex Pharmaceuticals' market value can be influenced by many factors that don't directly affect Vertex Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vertex Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vertex Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vertex Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.